Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 5

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
     15,873,113  
     2  
     119,887  
     (98,180) 
     (2,837) 
     18,872 

    Common Stock  
    Additional paid-in capital  
    Accumulated deficit  
    Foreign currency translation reserve  
    Total Stockholders’ Equity (Deficit) 

    Share  
    Amount  
    Amount  
    Amount  
    Amount  
    Amount 

    #  
    $  
    $  
    $  
    $  
    $ 
  
    Balance at September 30, 2023 
     15,873,113  
     2  
     116,491  
     (92,939) 
     (3,764) 
     19,790 
  
    Stock-based compensation 
     -  
     -  
     3,396  
     -  
     -  
     3,396 
  
    Share issuance 
     -  
     -  
     -  
     -  
     -  
     - 
  
    Net loss 
     -  
     -  
     -  
     (5,241) 
     -  
     (5,241)
  
    Currency translation adjustment, net of tax 
     -  
     -  
     -  
     -  
     927  
     927 
  
    Balance at December 31, 2023 
     15,873,113  
     2  
     119,887  
     (98,180) 
     (2,837) 
     18,872 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

3

INCANNEX HEALTHCARE INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the six months ended December 31, 

    2024  
    2023 
  
    Cash flows from operating activities: 

    Net loss 
    $(11,313) 
    $(5,968)
  
    Adjustments to reconcile net loss to